Application of Megavoltage Imaging to Reduce Artifact After Seed Implants

William St Clair

Status: Completed

Conditions: Prostate Cancer

Treatments: Radiation: MVCT

Study type: Observational

Funder types: Other

Identifiers

NCT01810627

13-RAD-01

Details and patient eligibility

About

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

Enrollment: 10 patients

Sex: Male

Ages: 50 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion criteria

Trial design

10 participants in 1 patient group

MVCT

Description:

Patients will receive an additional MVCT scan at their one month follow up visit.

Treatment:

Radiation: MVCT